These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 36748719)
1. Correlation of the surface expression of thymic stromal lymphopoietin receptor with the presence of CRLF2 gene rearrangements in children with B-lineage acute lymphoblastic leukemia. Demina I; Zerkalenkova E; Soldatkina O; Kazakova A; Semchenkova A; Goncharova M; Novichkova G; Maschan M; Karachunskiy A; Olshanskaya Y; Popov A Int J Lab Hematol; 2023 Jun; 45(3):337-343. PubMed ID: 36748719 [TBL] [Abstract][Full Text] [Related]
2. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort. Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401 [TBL] [Abstract][Full Text] [Related]
3. High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia. Juárez-Velázquez MDR; Moreno-Lorenzana DL; Martínez Anaya DA; Hernández Monterde EA; Aguilar-Hernández MM; Reyes-León A; Chávez-González MA; López Santiago N; Zapata Tarrés M; Juárez Villegas L; Rivera Sánchez N; Soto Lerma O; Vega-Vega L; Rivera Luna R; Pérez-Vera P Cytokine; 2022 Jul; 155():155896. PubMed ID: 35537330 [TBL] [Abstract][Full Text] [Related]
4. CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways. Moreno Lorenzana D; Juárez Velázquez MDR; Reyes León A; Martínez Anaya D; Hernández Monterde A; Salas Labadía C; Navarrete Meneses MDP; Zapata Tarrés M; Juárez Villegas L; Jarquín Ramírez B; Cárdenas Cardós R; Herrera Almanza M; Paredes Aguilera R; Pérez Vera P J Pathol Clin Res; 2021 Jul; 7(4):410-421. PubMed ID: 33890726 [TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Russell LJ; Capasso M; Vater I; Akasaka T; Bernard OA; Calasanz MJ; Chandrasekaran T; Chapiro E; Gesk S; Griffiths M; Guttery DS; Haferlach C; Harder L; Heidenreich O; Irving J; Kearney L; Nguyen-Khac F; Machado L; Minto L; Majid A; Moorman AV; Morrison H; Rand V; Strefford JC; Schwab C; Tönnies H; Dyer MJ; Siebert R; Harrison CJ Blood; 2009 Sep; 114(13):2688-98. PubMed ID: 19641190 [TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of Wang J; Sun K; Chen WM; Wang X; Li LD; Hao Y; Xu N; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Jiang Q; Qin YZ Leuk Lymphoma; 2023 Mar; 64(3):698-706. PubMed ID: 36642937 [TBL] [Abstract][Full Text] [Related]
7. Combined analysis of Cui L; Gao C; Wang CJ; Zhao XX; Li WJ; Li ZG; Zheng HY; Wang TY; Zhang RD Leuk Lymphoma; 2021 Feb; 62(2):410-418. PubMed ID: 33054468 [TBL] [Abstract][Full Text] [Related]
8. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience. Konoplev S; Lu X; Konopleva M; Jain N; Ouyang J; Goswami M; Roberts KG; Valentine M; Mullighan CG; Bueso-Ramos C; Zweidler-McKay PA; Jorgensen JL; Wang SA Am J Clin Pathol; 2017 Apr; 147(4):357-363. PubMed ID: 28340183 [TBL] [Abstract][Full Text] [Related]
9. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. Cario G; Zimmermann M; Romey R; Gesk S; Vater I; Harbott J; Schrauder A; Moericke A; Izraeli S; Akasaka T; Dyer MJ; Siebert R; Schrappe M; Stanulla M Blood; 2010 Jul; 115(26):5393-7. PubMed ID: 20378752 [TBL] [Abstract][Full Text] [Related]
10. [Clinical Features and Prognosis of Acute Lymphoblastic Leukemia Children with P2RY8-CRLF2 Gene Rearrangement]. Zheng YZ; LE SH; Zheng H; Hua XL; Chen ZS; Zheng L; Chen C; Li M; Cai CX; Yang JH; Chen YQ; Gao QL; Chen YY; Li J; Hu JD Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):311-315. PubMed ID: 33812392 [TBL] [Abstract][Full Text] [Related]
11. Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Rasekh EO; Atef AM; Khalil M; Ebeid E; Madney Y; Hamdy N Clin Lab; 2021 Jan; 67(1):. PubMed ID: 33491417 [TBL] [Abstract][Full Text] [Related]
12. Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein. Qin H; Cho M; Haso W; Zhang L; Tasian SK; Oo HZ; Negri GL; Lin Y; Zou J; Mallon BS; Maude S; Teachey DT; Barrett DM; Orentas RJ; Daugaard M; Sorensen PH; Grupp SA; Fry TJ Blood; 2015 Jul; 126(5):629-39. PubMed ID: 26041741 [TBL] [Abstract][Full Text] [Related]
14. GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Madzio J; Pastorczak A; Sedek L; Braun M; Taha J; Wypyszczak K; Trelinska J; Lejman M; Muszynska-Roslan K; Tomasik B; Derwich K; Koltan A; Kazanowska B; Irga-Jaworska N; Badowska W; Matysiak M; Kowalczyk J; Styczynski J; Fendler W; Szczepanski T; Mlynarski W Genes Chromosomes Cancer; 2019 Sep; 58(9):619-626. PubMed ID: 30859636 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia. Hassan NM; Abdellateif MS; Radwan EM; Hameed SA; Desouky EDE; Kamel MM; Gameel AM Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):e376-e385. PubMed ID: 34987014 [TBL] [Abstract][Full Text] [Related]
16. Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients. Vetter T; Borowski A; Wohlmann A; Ranjan N; Kuepper M; Badura S; Ottmann OG; Friedrich K Leuk Res; 2016 Jan; 40():38-43. PubMed ID: 26652578 [TBL] [Abstract][Full Text] [Related]
17. Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL. Tian Z; Shi C; Yang G; Allen JK; Shi Q; Al-Shami A; Olson JW; Smith MG; Chang Q; Kaur J; You J; Lofton TE; Gonzalez MA; Zhang Q; Zha D; Tasian SK; Jain N; Konopleva MY; Heffernan T; Molldrem JJ Leukemia; 2023 Oct; 37(10):2006-2016. PubMed ID: 37634013 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood. Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317 [TBL] [Abstract][Full Text] [Related]
19. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. van der Veer A; Waanders E; Pieters R; Willemse ME; Van Reijmersdal SV; Russell LJ; Harrison CJ; Evans WE; van der Velden VH; Hoogerbrugge PM; Van Leeuwen F; Escherich G; Horstmann MA; Mohammadi Khankahdani L; Rizopoulos D; De Groot-Kruseman HA; Sonneveld E; Kuiper RP; Den Boer ML Blood; 2013 Oct; 122(15):2622-9. PubMed ID: 23974192 [TBL] [Abstract][Full Text] [Related]
20. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia. Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]